How to Buy Immunocore Holdings Stock
Immunocore Holdings PLC
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.
Immunocore Holdings stock last closed at $60.23, up 1.29% from the previous day, and has increased 2.07% in one year. It has overperformed other stocks in the Biotechnology industry by 0.2 percentage points. Immunocore Holdings stock is currently +42.69% from its 52-week low of $42.21, and -21.76% from its 52-week high of $76.98.
At the moment, there are 49.82M shares of IMCR outstanding. The market cap of IMCR is $3.00B. In the last 24 hours, 373,867 IMCR shares were traded.
How to Buy Immunocore Holdings Stock
Wondering how to invest in Immunocore Holdings stock? Here's how.
- Figure out where to buy Immunocore Holdings stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you figure out where to buy Immunocore Holdings stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Select your payment method and add your information.
- Analyze Immunocore Holdings stock: The Immunocore Holdings ticker symbol is IMCR. Is Immunocore Holdings stock a good investment? Should you buy shares of IMCR? How do IMCR's underlying business fundamentals look? Do top analysts think Immunocore Holdings is a good buy? Why has IMCR's stock price moved recently? (Hint: Our stock market research website can help you decide if IMCR is a good stock to buy).
- Make your IMCR buy order: Decide if you will purchase IMCR shares at the current market price or use a limit order to buy IMCR shares at a specific price.
- Keep an eye on your IMCR investment: Create a watchlist to get the latest news on your investment in Immunocore Holdings shares.
Step 1: Figure out where to buy Immunocore Holdings stock
You need an online brokerage account to access the NASDAQ market and buy IMCR stock.
Our recommended brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Industrials, New York to London — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal info so you can invest in IMCR today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to start your new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have finished signing up on the stocks app, you need to deposit funds:
Check out the video below if you need help transferring money into your investment account.
Step 4: Analyze Immunocore Holdings stock
After you have identified the best place to buy Immunocore Holdings stock, it's absolutely critical to research their stock prior to buying, so you truly comprehend the risk as well as the opportunity.
Immunocore Holdings quick stats
IMCR Due Diligence Checks
WallStreetZen was created to help everyday investors perform more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on IMCR's stock page.
What is the fair value of IMCR stock?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge IMCR's true value.
Using relative valuations metrics:
- IMCR may be overvalued based on its P/B ratio of 8.14x, relative to Biotechnology industry P/B ratio of 6.01x
You can access more valuation analysis on IMCR's stock here.
Is IMCR a healthy company?
Signs that IMCR is financially healthy:
- Total IMCR debt is lower than 5 years ago, relative to shareholder equity.
- IMCR has cash burn of 2485000. It has sufficient cash and short-term investments to cover this for at least one year.
- IMCR has $442.63M in cash and short term investments. This is sufficient to cover its annual cash burn of $2.49M.
- There are more short-term assets than long-term liabilities on the IMCR balance sheet.
- There are more short-term assets than short-term liabilities on the IMCR balance sheet.
- IMCR profit margin has gone up from -30.1% to -22.2% in the past year.
Signs that IMCR is not financially healthy:
- IMCR has a relatively high debt to equity ratio of 0.62.
Do Wall Street analysts think it's a good time to buy IMCR stock
Out of 8 Wall Street analysts who give recommendations on IMCR, the consensus analyst rating on IMCR is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Latest IMCR Analyst Ratings
Graig Suvannavejh, a bottom 3% analyst from Mizuho maintains IMCR with a strong buy rating and raises their IMCR price target from $86.00 to $90.00, on Mar 5, 2024.
Mizuho's Graig Suvannavejh raised their price target on Immunocore Holdings (NASDAQ: IMCR) by 4.7% from $86 to $90 on 2024/03/05. The analyst maintained their Strong Buy rating on the stock.
After assessing Immunocore Holdings' 2024/02/28-dated Q4 and FY 2023 earnings report and call, Suvannavejh predicted several data readouts in 2024.
Earnings Report
Immunocore Holdings reported:
For Q4 2023:
- Loss per share of $0.40, compared to Q4 2022’s loss of $0.63.
- Revenue of $70.16M, up 22.4% Y/Y.
For FY 2023:
- Loss per share of $1.13, which missed the consensus estimate by 41% but beat, by 1.7%, FY 2022’s $(1.15).
- Revenue of $249.4M, which beat the consensus estimates by 25% and, by 44%, FY 2022’s $174.4M.
Management did not provide financial guidance in its press release or earnings call.
CEO Bahija Jallal commented: “In the last 5 years, Immunocore has transformed from a research organization to a revenue-generating, sustainable company.
“We look forward to the next 5 years, when we maximize the potential of KIMMTRAK, expect to launch our PRAME ImmTAC therapy, and advance our clinical candidates across oncology, infectious diseases, and autoimmune diseases."
Justin Kim, a top 23% analyst from Oppenheimer reiterates IMCR with a buy rating and raises their IMCR price target from $85.00 to $87.00, on Feb 29, 2024.
Bill Maughan, a top 36% analyst from Canaccord Genuity maintains IMCR with a hold rating and raises their IMCR price target from $60.00 to $63.00, on Feb 29, 2024.
You can dive deeper into what analysts are forecasting on the Immunocore Holdings stock forecast page.
Metrics for Advanced IMCR Traders
Is IMCR Growing Revenue?
Last year, IMCR revenue was $249.43M. In the past five year, IMCR's revenue has increased by 53.19% per year. This was faster than the Biotechnology industry average of 29.63%.
Dig into IMCR's earnings and revenue performance here.
What are IMCR insiders up to?
In the past year, executives and large shareholders at IMCR have bought as many shares as they have sold.
Leger Tina Amber St, CHIEF HR OFFICER of IMCR, was the latest IMCR insider to sell. They sold $280,262.50 worth of IMCR shares on Apr 1, 2024.
Research more about who owns IMCR shares here.
Can I get consistent income from IMCR stock?
No, Immunocore Holdings doesn't provide an income stream by paying out dividends.
What do other traders have to say about IMCR?
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your IMCR buy order
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly the best for newer investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a given dollar amount, place a limit order.
Hit the Open Trade button and eToro will place your order.
If you want additional info about buying stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your IMCR investment
Now that you own some shares in IMCR, you'll want to keep up with your investment.
Put IMCR on a watchlist to track the latest developments regarding your IMCR stock.
IMCR Feed
How to Buy Stock in Immunocore Holdings
To reiterate, here are the 6 steps to buy Immunocore Holdings stock:
- Figure out where to buy Immunocore Holdings stock
- Open a brokerage account
- Deposit funds into your investment account
- Analyze Immunocore Holdings stock
- Make your IMCR buy order
- Keep an eye on your IMCR investment
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to watch your investment in Immunocore Holdings, click below.
Other Articles You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.